Chargement en cours...

Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?

<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Imyanitov Evgeny N
Format: Artigo
Langue:Inglês
Publié: BMC 2009-04-01
Collection:Hereditary Cancer in Clinical Practice
Accès en ligne:http://www.hccpjournal.com/content/7/1/8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!